SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as the community discusses the National Oceanic and Atmospheric Administration's (NOAA) determination that its consolidated deep-seabed mining application is in "substantial compliance," marking a significant regulatory milestone for critical mineral extraction. This development, alongside an expanded project area, reinforces bullish sentiment regarding the company's role in securing vital metals for national security and energy independence amid global geopolitical shifts.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending with high anticipation for its imminent Phase 3 REGAL trial data readout for AML, driven by community enthusiasm for "curative outcomes," potential for a massive short squeeze, and buyout speculation, despite some investor concerns regarding valuation and trial uncertainties.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

Relmada Therapeutics is trending due to positive 12-month Phase 2 interim data for its bladder cancer candidate NDV-01 and an oversubscribed $160 million private placement, driving a significant volume surge. The community is actively discussing potential continued upward momentum for this low-float biotech, while some caution about near-term price movements following the financing.

Aureus Greenway Holdings, Inc. engages in the ownership and operation of public golf country clubs, namely Kissimmee Bay Country Club and Remington Golf Club. It operates through the following segments: Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental, Membership Dues, Food and Beverage Services, and Ancillary Services and Amenities. The Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental segment is involved in the collection of fees for every round of eighteen holes, provision of driving ranges for practice, sale of golf apparel and equipment, and rental of golf products and cars. The Membership Dues segment refers to the membership fees for customers to access the club's facilities and services for a set period or daily at the point of sale. The Food and Beverage Services segment provides culinary services such as catering. The Ancillary Services and Amenities segment offers leisure activities hosted in an on-premises clubhouse, kitchen, bar, and dining area. The company was founded on December 22, 2023 and is headquartered in Kissimmee, FL.

Aureus Greenway Holdings Inc.

Aureus Greenway's merger with Trump-backed drone manufacturer Powerus is driving intense discussion as it pivots the company into the defense-drone sector, exciting bullish investors with prospects of government contracts and a short squeeze, while sparking strong skepticism regarding potential dilution and insider dealings.

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

CAMP4 Therapeutics Corp.

Calamp Corp.

Camp4 Therapeutics is surging after announcing an oversubscribed $100 million private placement to advance its SYNGAP1-related disorder treatment, with the community actively discussing low float dynamics and potential for a significant short squeeze amid heavy trading volume.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

Upcoming 1-for-5 reverse stock split is driving significant conversation around MSTY, with investors widely concerned about sustained NAV erosion and declining dividend payouts. The community actively debates the fund's long-term viability and its performance, which is closely tied to MicroStrategy and Bitcoin.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending as its subsidiary secured new ICE contracts for "skip tracing services" and was added to a pre-qualified vendor list for a significant detention system overhaul. This fuels investor discussions about the company's undervalued assets and potential for growth amid evolving immigration enforcement policies.

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.

Adlai Nortye Ltd. - ADR

Adlai Nortye Ltd. American

Adlai Nortye Ltd. is a hot topic after securing a $140 million private placement at $6.50 per share with major institutional backing, complementing a recent licensing deal for its pan-RAS inhibitor potentially valued at up to $230 million. The community debates whether the institutional vote of confidence and deal pipeline signal a massive upside or if the current trading levels are overextended given the financing price.

Literally a dog wif a hat, dogwifhat (WIF) is a meme coin that's part of the ever-growing ecosystem of digital currencies on the Solana blockchain. This token brings a lighthearted twist to cryptocurrency, featuring a playful dog with a hat as its mascot, symbolising a more whimsical approach to the often serious domain of digital finance.

dogwifhat

Dogwifhat (WIF) is facing extreme volatility and polarized community sentiment, driven by recent FUD and rumors of a potential delisting, while many traders debate if current dips represent a significant buying opportunity for the meme coin.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending due to a significant Q4 earnings beat, with revenue and EPS far exceeding expectations, fueling community optimism for Miplyffa's potential European approval and discussions of the stock's deep undervaluation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


MAIL
IncrediMail, Ltd.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MAIL News

MAILIncrediMail, Ltd.